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1. SYNOPSIS OF HISTORY
I HAVE been asked to speak to you this evening on the subject of B C G vaccination
against tuberculosis. For the benefit of those of you who are not familiar with the
story, I thought I would give a brief outline of the history of the development of
the vaccine.
'T'he vaccine is named after Calmette and Gu-erin, the two pioneer workers in this
field of medical research.
In 1908 Calmnette started to grow this particular strain of bovine tubercle bacillus
oin special culture media. 'T'he research continued for many years, using different
experimental animals to determine first, the harmlessness of the vaccine and
second, to test its immunizing powers. Finally, in 1923, the plunge was taken and
the vaccine was given by Weill Halle to newborn infants in Paris. At this period it
was given by mouth dissolved in milk.
'I'hese years of experiment were required in order to produce a vaccine that is
stable in virulenice and potency, one that is incapable of producing a progressive
tuberculous disease and at the same time has the power of conjuring up the
protective mechanisms of the body, so that a possible future virulent infection
will be successfully resisted.
The vaccine used in every country is grown from the original strain of Calmette
bacillus obtained from the Pasteur Institute in Paris, but the subsequent methods
of culture vary in different countries as do the technique of vaccination and the
dosage prescribed.
In France the organism, originally cultured on bile potato, is now grown on
Sauton potato in Roux tubes, and it is administered in the main by the scarification
method. In Russia the vaccine is still largly given by the oral route, while in
Norway, the multiple puncture method of administration is favoured by some
workers. The administration of the vaccine commenced in Scandinavia in 1925
and about a year later Heimbech of Norway was the first to try giving the vaccine
by subcutaneous injection, but this method was soon abandoned, as it gave too high
a proportion of local abscesses. In 1928, Dr. Wallgren of Sweden introduced the
intradermal techniique for B C G innoculation, which is now the standard method
used in the Scandinavian countries and the one which has been adopted here in
Northern Ireland.
The vaccine used by the Northern Ireland Tuberculosis Authority is supplied
from the State Serum Institute in Copenhagen and is delivered by air mail once
a week to Belfast.
422. LABORATORY 'tECHNIQUE IN PRODUCTION OF B C G
In Denmark the laboratory concerned with the production of this vaccine, is a
self-contained unit and is kept solely for this purpose; no other type of tubercle is
allowed into the laboratory and a most rigorous control is kept on all the personnel.
These precautions are now taken in all laboratories manufacturing B C G and are
enforced to prevent any possible repetition of the Lubeck disaster, when a virulent
culture of human bacilli was accidentally mixed with the vaccinie.
Originally, as I have said, the culture medium was bile potato which had the
power of fixing the virulence of the bacilli at a very low level. Nowadays in Denmark
the strain is kept oIn a synthetic fluid medium called the Sauton medium and is
transferred regularly from one culture flask to another every ten days. Sauton
consists of an amino-acid, asparagine, various salts and glycerine. It is diluted
1 in 3 with redistilled water. Ihis medium is preferred for growing B C G as its
constituents are not variable quantities like beef or broth or egg.
The keeping of the strain, so that the potency of the vaccine remainis constant,
demands great experience anid skill and even with this it has shown some variations,
but only within certain limits. These variationis are noted ancd controlled by animal
innoculations, carried out on a special breed of' white guinea-pig, from each batch
of vaccine manufactured. TIhe results of these investigations are not knowni, of
course, until months after that particular batch of vaccine has been usedl, but this
is not considered to be of great practical importance as variations in potency of the
vaccine and vitality of the organism only occur very gradually.
For the preparation of the vaccine, Calmette bacilli are grown on Sauton medium
and form a thick, crinkled, cream-coloured veil on the surface of the fluid. A
fourteen-day-old culture is used. The flask containing the culture is shaken
vigorously and poured into a Birhaug apparatus from which the dried culture mass
is extracted and weighed. After this it is placed in a large bottle and emulsifiedl
by shaking up with stainlless steel pellets so that the bacilli lie almost individually
and not in clumps. By adding fluid, a suspension is made so that it contains 1/4 mg.
B C G culture in 1 c.c. of fluid. Diluted Sauton medium is used as the diluent.
The vaccine is manufactured once a week, but not packed or released from the
laboratory until the results of two sets of sterility tests become available. rests
for aerobic organisms are made on blood agar plates and for anarobic organisms,
on half solid agar with and without ha-moglobin. Any contaminated flask is
destroyed forthwith. The vaccine is thus six days old before it leaves Denmark
and it is intended for use within fourteen days of manufacture, as after this its
efficiency deteriorates rapidly. The optimum temperature for preserving the vaccine
is 2°-4°c., and once the vaccine is delivered in Belfast it is storedi in a refrigerator
used solely for this purpose andc kept at this temperature. rhe vaccine is made up in
sealed glass ampoules of 1 c.c. andl 5 c.c., enouglh for tein and fifty cases,
respectively, and each batch has a separate number and is stamped with the date
of manufacture. There is hope of producing a dried vaccine, in the near future,
which can be diluted before use and which will keep indefinitely.
433. SELECTION OF CANDIDATES FOR B C G
At the present time it is not possible to offer B C G to everyone wlho wants to
have it and special groups of the populationi are being selected for priority treatment.
These groups include:
(a) Newborn babies of tuberculous motlhers, born in maternity hospitals and
isolated at birth from their source of infection. As a placental infection is a
medical curiosity this has the advanltage of eliminating all pre-vaccinial testilng
and isolation. The disadvantage lies in the fact that infants have poorly
developed powers of producing anti-bodies and take a long time about it,
so that a considerable proportion require to have the vaccination repeated
and the successful cases take eight to twelve weeks to effect conversion,
which places a considerable strain on the cot situation in the maternity
hospitals. I would like to say at this point, how extraordinarily co-operative
both the Jubilee Hospital and the Royal Maternity Hospital have been in
affording us this facility.
(b) Non-inifected chiild or adolescent contacts ol cases of tuberculous (lisease.
(c) Young adults subjected to special risk of inifectioni, e.g., nurses, me(lical
stu(lents and social workers, laboratory technicians, etc.
As the scheme expands, we hope to be able to offer vaccinationi to atll wheo are
suitable and who wish to avail themselves of the protection.
4. SIGNIFICANCE OF I UBERCULIN TESTING
Tuberculin is the toxin of the tubercle bacillus and was isolated by Robert Koch
in 1889. This substance gives a reaction when it comes in contact with the skini
and tissues of someone who has been infected by tubercle bacilli, but no reaction
in those who have not been so infected.
A number of well controlled surveys have demonstrated that the reactor to
tuberculin has a higher resistance to tuberculosis than the non-reactor, when the
general resistance is the same and if two groups of the population are taken one
composed of reactors to tuberculin and the other of non-reactors, living under the
same conditions and equally exposed to tuberele bacilli, five times as many cases
of tuberculosis will develop amongst the nons.reactors as among the reactors.
Herein lies the r6le of B C G, for if the skin sensitivity is co-existent with the
development of specific immunity (which is generally but not universally admitted)
then with B C G one can protect a previously non-infected person by giving him a
controlled infection, without any risk of acquiring the disease, but providing at
least as good protection as that afforded by a naturally acquired infection.
5. CHOICE OF TESTS AND) TECHNIQUE OF TUBERCULIN TESTING
Prior to vaccinationi the routine procedure of tuberculin testinig adopted by the
Northern Ireland Tuberculosis Authority depends on whether the candidate for
vaccination is a child or an adult, as in the former we try to avoid any unnecessary
injections.
44In children under twelve years we do a preliminary skin test with Allen &
Hanbury's tuberculin diagnostic jelly, using an abrasive on the skin and cleaning
the area with acetone first. If this test is negative, X-ray examination and checking
of contacts is completcd and then three days before the proposed (late of vaccina-
tion, xve do an iitradermal tuberculin test xvith Mantoux 1/100 ,giVing 1/10 of
a c.c. into the outer aspect of the middle thir(d of the left forearm. Tnhis test is
rea(I in 72 hours anid if negative the child is vaccinate(d immediately.
In the casse ol adults and older children the preliminary test is dlonle with 1/10,000
Mantoux, if the result is unequiv-ocably negative in sev,enty-two hours, we go
straight to 1/100, if the result is doubtful we do an intermediate test with
Mantoux 1/1,000.
If, for aniy reason, it is impossible to read tuberculin tests after three (lays, it is
preferable to read them on the fourth rather than the second day, as
noni-specific reactions have not always siubside(d in forty-eight hours and these
mayr conlfuse the interpret,ation of the result.
\'Ve try also to remin(d ourselves that tuberculini testing should not be carried
out when there is an epi(lemic of measles and whoopiilg-cough about, as these
infections, and1 possible others, also, have the power of temporarily changing
tuberculin positive reactors into tuberculin negative ones.
On occasions wve have to ask the patient's general practitioner or district nurse
to read and report on the results of tuberculin tests, when this occurs we tell him
that to read a tuberculin jelly test as positive, vesticulation must be present and
to read an intradermal test as positive, there must be cedema or induration present
to a minimum diameter of 6 mm. Rediness alone does not constitute a positive
reaction in either case.
6. I ECHNIOUE OF CAILMETTE X"ACCINATION
Now to come to the vacciniation itself. As I have explained, vaccination is only
given to people wvith negative tuberculin tests to a strength of Manitoux 1/100,
the final test being made three or four days before the proposed date of vaccination.
A-kt this point I would like to say that no actual harm is done if tuberculin
positive case is inadvertently vaccinated, but it may give rise to unpleasant local
reactioni at the site of vaccitnation which would discourage people from being
vaccinate(d and wvould certainly (liscourage me from being a vaccinator. I have not
yet had personal experience of a Koch's phenomenon, but a colleague working
with B C G describedi a case to me, where the result was not only a local reaction
in forty-eight hours resembling an acute cellulitis, but also a temperature of 105'F.,
with meniingeal svmptoms and a widely distributed urticarial rash.
Another reason for taking all precautions to avoid vaccinating tuberculin positive
reactors is that some of these cases might be latent or early cases of tuberculosis,
and if the disease manifested itself soon after the adminstratioin of the vaccine the
vaccine might be blamed for producing the disease.
45
PInstructions for use:-
The vaccine must be vigorously shaken before use, as it is necessary to have the
bacillary particles evenly distributed in suspension.
The vaccine is given intradermally into the left deltoid region. A successful
injection shows a bleb about 10 mm. in diameter with indentations for the hair
follicles. If this does not occur the injection has been given too deeply. The dose
is 1/10 of a c.c. except in infants under six months, when two injections of .1 c.c.
are given, e.g., 1/10 c.c. into each deltoid region.
No antiseptic is used on the skin. Any solution left over in the ampoule is
destroyed at once.
The syringe used for the vaccination is the ordinary 1 c.c. tuberculin syringe,
divided into tenths. The needles used are No. 20 short bevelled platinum-iridium
needles, if we are lucky enough to get them.
The syringes and needles used for B C G are sterilized by boiling and must not
be used for tuberculin testing or any other purpose, as the vaccine adheres to the
surface and is not removed by sterilization.
7. POST-VACCINAL CONTROL
In order to see if the vaccination has taken, a control should be made six to
eight weeks after vaccination in adults and eight to twelve weeks after in children.
At this examination the site of vaccination is observed and a tuberculin test is
made with tuberculin jelly in children under twelve years and with Mantoux 1/1,000
in adults and older children. If negative on reading at seventy-two hours, the
test should be repeated using Mantoux 1/100 in both cases. An interesting point is
that the tuberculin test after successful vaccination looks different from an ordinary
positive reaction. The area is flatter and bluer in colour. If the individual gets
super-infected subsequently the appearence changes to that of a natural tuberculin
reactor. Futher tuberculin testing will be carried out every year to see that
tuberculin positivity is preserved and that the protection is being maintained. If
the patient has reverted and is negative, re-vaccination is recommended.
Local reaction at the site of vaccination at six to eight weeks, measures about
5 mm. and there is usually a slight oozing from the centre which persists for about
a week. A dressing with a gauze strip can be applied but bathing and all normal
activities are permitted. A crust forms when the oozing stops, and finally there
remains a small depressed white scar. Occasionally there is some enlargemernt of
the supra-clavicular and axillary glands about two months after vaccination.
There is no constitutional disturbance at any time.
Complications with the intradermal method of vaccination are, fortunately,
rare but they do occur and include local abscess formation, and suppuration of
the regional lymph glands, they occur most frequently in small children.
These complications clear up spontaneously after a time, though the lymph node
may require aspiration and this may need to be repeated in about a month.
Sometimes the vaccinated person does not report until the abscess has burst. If this
46has occurred no special treatment is indicated and incision should be avoided;
it must be remembered that these lesions heal by themselves and should not be
considered or treated as ordinary tuberculous abscesses.
Hitherto it has not been our practice to make any mention about complications
to prospective candidates for vaccination but I think it may be necessary to revise
this policy, as otherwise the child or its parent may be unduly alarmed when they
do arise.
8. ISOLATION OF CONTACTS OF ACTIVE CASES
Special isolation precautions are taken when vaccinating contacts of active
cases of tuberculosis.
In these cases a preliminary tuberculin test is made in the normal way. The
person to be vaccinated is then separated from the source of infection for a period
of six weeks, either by placing the patient in a sanatorium or by removing the
vaccinee from the home. At the end of the six weeks pre-vaccinal period another
tuberculin test is made and if this is negative, vaccination is performed immediately
on reading the test. The vaccinated person must remain away from the source
of infection until the vaccination has "taken" and the tuberculin test is positive, an
overall period of about three months.
The precaution of pre-vaccinal isolation is to avoid giving B C G when the
patient may be in the preallergic stage of an active infection, and that this is a very
real risk is demonstrated by the fact that in our own small series of cases we have
had nearly a dozen cases of natural conversion in the pre-vaccinal period. A couple
of these I shall be discussing later in further detail.
The object of the post-vaccinal isolation is to avoid any chance of the
individual contracting an infection before the specific protection given by the
vaccine has had time to develop.
9. DURATION OF PROTECTION AFFORDED BY B C G
A good many of our patients enquire how long the vaccination will remain
effective in affording protection against tuberculosis and how complete the
protection is.
The answer to the first question probably depends on whether or not the
individual after vaccination comes in contact with active tuberculous infection.
If this occurs the protection afforded by the vaccine will be constantly boosted and
will probably last indefinitely. In the case of those who have no contact with
infection after vaccination, it is believed that the protection will last for at least
five years.
The figure has been based on an investigation at an island called, Bornholm,
where bovine tuberculosis has been completely eradicated and where there are
practically no sufferers from tuberculosis. Here a mass vaccination of the entire
non-reacting inhabitants was carried out; in a follow-up examination five years
later 90 per cent. of the population were still Mantoux positive.
In answer to the second question as to how complete is the protection afforded,
I quote some of the claims for vaccination which came from Scandinavia.
17AIMS ANI) CLAIMS OF B C G VACCINATION
In over a million cases of successful vaccination, no case of tuberculous
meningitis or mililry tuberculosis has developed in a child under two years, though
the majority of cases have been in close association with infective (liscase after
inversion.
In the Copenhageni district where systemiiatic v7accination of non-reactors
in tuberculous families is carriedl out, there has been no (leath from tuberculosis
amoing vacciniated children. Infections, when they do occur, and whose tuberculous
nature is confirmed by finding the causative organism are usually benign in
character, and clear as quickly as though they were non,specific in origin, e.g.
hilar adenitis or pleural effusion.
There is still a good dleal of controversy about the amount of protection
afforded against progressive pulmonary tuberculosis of human origin, but in
Scandinavia it is consi(lered to be at least as high as that conferred by a natural
process of infection an(l the infection incidence is quotel as one-fifth of that which
occurs in people who were not reactors though having had a primary exposure.
10. 13 C G EXPERIENCE IN NORT1HERN 1RELAND
Before finishing 1 woul(d like to give a brief outline of our cxperience Nxith B C G
since the programme started about eight months ago.
TIhle number of vaccinations carried out is approximately ... ... 1000
Number of people wvith completed post-vaccinal tests about ... ... 800
Number of non-convertors after B C G ... ... ... ... 2
1. Newborn infant. No local reaction and negative to Mantoux 1/100 at six
weeks. Re-vaccinated at nine and a half weeks, when still neglative to 1/100.
Ihe second vaccination with a double (lose was successful.
2. New-born infant. No local reaction anid Mantoux 1/100 negative at six
wveeks. This child was removed to an orphanage outside Northern Ireland,
and I have not pursued the case, as no further conltact is anticipated with the
tuberculous mother.
NUMBER oc DELAYED CONVERSIONS
About a dozen cases mainly of the student age groups have been negative at six
weeks to Mantoux 1/100 but strongly positive when tested about ten weeks after
vaccination.
I think it is probablv inadvisable to re-vaccinate uniler twelve weeks, especially
if the vaccination site shows a typical "take".
COMPLICATIONS
One small subcutan-eous abscess 15 mm. in diameter in a child of four years,
with ulcerated core 3 mm. in diameter with purulent (hisclharge. Now healing
satisfactorily.,
Two axillary lymph nodes abscesses in children of two years and seven years
respectively. Each required aspiration. The general health of the children was
48excellent and pre- and post-vaccinal X-rays were normal. Healing is now
occurring in both cases.
SEVERE REACTIONS
About six severe local reactions confined to members of two exceptionally dirty
families. I attributed these sores to scratching and secondary infection and not to
the vaccination. The sites were cleaned and covered with a dressing and the nurse
visited within a fortnight and reported that the local reactions were healing
satisfactorily.
About twelve cases altogether have had palpable glands in the axilla, typically
placed anteriorally and up against the chest wall; when these are present they
are clearly visible on X-ray.
GENERAL OBERVATIONS
All vaccinations are done on a voluntary basis and a consent form, signed by the
parent or guardian, is obtained for any vaccinee under twenty-one years.
The vaccination period necessitates a minimum of five visits :-e.g. preliminary
test, X-ray, pre-vaccinal test, vaccination and post-vaccinal test. Subsequently,
each case is to have an annual review with tuberculin test and X-ray. Any revertors
will be offered re-vaccination.
For every vaccinated case, an average of four other members of the household
are reviewed apart from the known source of contact. This involves X-ray in the
majority of cases and sputum examination in a few. In all; explanation,
exhortation, encouragement and reassurance.
NATURAL CONVERSIONS
As I have already said, about a dozen cases of natural "conversion" have occurred
in the pre-vaccinal period
In each case the patient has been referred back to the clinic for observation.
In about half the cases there was X-ray evidence of disease and about the same
number had some disturbance in health, only one case complained of a cough.
Several of them have been very instructive, notably:
1. Male infant 11 years. Examined at Central Tuberculosis Clinic,
Belfast, in July, 1949. T. Jelly negative. Mother admitted sanatorium in
in November, 1949. Child admitted to a Children's Hostel 7/11/49.
T. Jelly negative 15/11/49. X-ray nil same month. Six weeks pre-vaccinal
isolation to January, 1950, when Mantoux 1/100 was + +. Admitted to
Sanatorium with Tb. meningitis same month.
2. Male infant 18 months. T. Jelly and Mantoux negative in October, 1949.
Mother quiescent disease, but living in house with infectious case.
Vaccination defered till seven weeks after removal to new home, and when
called up Mantoux 1/100 was strongly positive.
3. Male child, 41 years. T. Jelly negative October, 1949. Infectious uncle out
on pass from sanatorium at Christmas. Mantoux 1/100+ + at pre-vaccinal
test in January, 1950. X-ray shows suspicious shadowing at left base.
491. T-io niurses repeatedly negative to MantouX 1/100) isolated fromi tuberCulous
wards for prc-vaccinial period and( fouLnd Mantoux 1/1(( positive at pre-
vaccinal test. No X-ray lesion, or disturbance in health in either case.
'l'he response to the B (C (G calpaigni hlas b)een very gratifying allnd in addition
to coIitact cases, there have hecn numerous enquiries from institutions, factories
anid schools. It would seem that expanlsion of the programme wkill be limitedl only
by our powers to expand.
Two developments most urgently required are increased X-ray facilities and
isolation for contacts of active cases (luring the vaccination period.
TShe technique of vaccination (loes niot presenlt any obstacle, but I thinki judgement
is requiredl in (leciding whom to vaccinate and when to vaccinate them. Moreover,
it must always be borne in mind by B C G enthusiasts, that vaccination against
tuberculosis is a good servant and a bad master, and that unless the people who
are vaccinated are assure(d that it is only one small factor in the preventive
campaign against tuberculosis, it miay do more lharmii than good, b1 engrendering in
tuberculous families a feeling of false security.
REVIEW
RECENT ADVANCES IN SOCIAL MEDICINE. By A. C. Stevenson, B.Sc.,
M.D., M.R.C.P., D.P.H., Professor of Social and Preventive Medicine, The
Queen's University of Belfast. J. & A. Churchill Ltd. 18s.
Titis book is a welcome addition to Churchill's wvell-known Recent Advances Series. In its 238
pages it deals in nine chapters with "a small group of subjects wvhich appear to be of importance."
The first chapter, on "Measurement of Grovth in Children," is a serious attempt to present
briefly some aspects of anthropometry, and to assess to what extent the formula of Tuxford and
others can be used to add or to check clinical findings. Tlhe author concludes that "no satisfactory
method has been devised whereby states of nutrition can be assessed by anthropometry." In this
chapter the meaning of the text is not always clear, e.g., on page 13 it is stated that, according
to Tuxford, wveight/height ratios increase by age roughly in harmonical progression;. a few lines
later we are told that height/weight ratios appear to advance in harmonical progression.
A quarter of the book, in two chapters, is devoted to the subject of infant mortality. A careful
study of these chapters will well repay the student or the practitioner, and they can be commended
in particular to the general practitioner. Indeed, the author has taken a great deal of trouble
to collect muich useful information and to present it in an attractive form.
Then follow chapters on day nur-series, the unmarried mother, problem families, and school
medical inspection, wlhich wrill readily commend themselves to all students of social medicine.
Chapter VIII, wvritten by Dr. E. A. Cheeseman, Lecturer in Mledical Statistics, Queen's
University, Belfast, deals clearly wvith "Some Applications of Statistical Methods." It can readily
be understood, even by non-miiathematical readers.
Ihe bibliogr-aphy at the end of the chapters indicates how wvidely Professor Stevenson has
studied the subjects (liscussed.
It is to be hoped that at no distant date the second. edition of this book, in a much enlarged
form, will appear, and will contain a similar clear account of a further group of important
subjects. J. B.
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